Survival probability loss from percutaneous coronary intervention compared with coronary artery bypass grafting

Umberto Benedetto1, Mohamed Amrani1, Toufan Bahrami1

  • 1Department of Cardiac Surgery, Harefield Hospital, London, United Kingdom.

Insights

Coronary artery bypass grafting (CABG) significantly reduces late-phase mortality compared to percutaneous coronary intervention (PCI) in patients with multivessel disease, regardless of age. This survival benefit of CABG over PCI is consistent across all age demographics.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Cardiac Surgery

Background:

  • The comparative survival benefits of coronary artery bypass grafting (CABG) versus percutaneous coronary intervention (PCI) for multivessel coronary artery disease (CAD) in older populations remain incompletely understood.
  • Investigating the age-specific impact of PCI versus CABG on patient survival is crucial for optimizing treatment strategies.

Purpose of the Study:

  • To determine if the survival advantage of CABG over PCI in multivessel CAD is influenced by patient age.
  • To analyze the relationship between patient age and the long-term survival outcomes following PCI compared to CABG.

Main Methods:

  • A propensity score-matched analysis included 6723 patients with multivessel CAD (1097 PCI, 5626 CABG).
  • Drug-eluting stents were predominantly used in the PCI group (83.5%).
  • Hazard ratios and confidence intervals were calculated for early (≤12 months) and late (>12 months) post-procedural phases across various age strata.

Main Results:

  • Over a mean follow-up of 5.5 years, CABG demonstrated superior survival rates compared to PCI (8-year survival: 90% vs. 75%, P < .001).
  • PCI offered no significant early survival benefit over CABG.
  • A significant survival disadvantage associated with PCI versus CABG was observed during the late hazard phase across all age groups, with hazard ratios consistently above 1.

Conclusions:

  • Coronary artery bypass grafting (CABG) is associated with a significant reduction in late-phase mortality compared to percutaneous coronary intervention (PCI) in patients with multivessel coronary artery disease.
  • This survival benefit of CABG over PCI is evident and consistent across all age groups studied.
Abstract